Skip to main content
. 2023 Jul 27;15(15):3809. doi: 10.3390/cancers15153809

Figure 3.

Figure 3

Comparison of serum galectin-1, -3, and -9 concentration in breast cancer patient serum, as determined by ELISA, by binary expression of overall hormone receptor, estrogen and progesterone receptor, and HER2 amplification determined using an immunohistochemical stain. HR, Hormone Receptor; ER, Estrogen Receptor; PR, Progesterone Receptor. * One-tail t-test.